logo-large
  • Browse Categories

Publications by authors named "Ed W McLean"

Claim this Profile
A
Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
Christopher McGuigan, Alshaimaa Hassan-Abdallah, Sheila Srinivasan, Yikang Wang, Adam Siddiqui, Ed W McLean

J Med Chem· November 2006


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.
John F Miller, C Webster Andrews, Michael Brieger, Eric S Furfine, Michael R Hale, Ed W McLean

Bioorg Med Chem Lett· April 2006


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
Christopher McGuigan, Sarah A Harris, Susan M Daluge, Kristjan S Gudmundsson, Ed W McLean

J Med Chem· May 2005


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity.
David L Musso, Felicia R Cochran, James L Kelley, Ed W McLean, Jeffrey L Selph

J Med Chem· January 2003


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: